MENLO PARK, Calif. (AP) — Corcept Therapeutics Inc. (CORT) on Thursday reported second-quarter profit of $20.2 million.

The Menlo Park, California-based company said it had profit of 17 cents per share. Earnings, adjusted for stock option expense and non-recurring costs, were 25 cents per share.

The drug developer posted revenue of $72.3 million in the period.

Corcept expects full-year revenue in the range of $285 million to $315 million.

Corcept shares have dropped 18% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $10.96, a decline of 17% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on CORT at

Get Trib headlines sent directly to you, every day.

* I understand and agree that registration on or use of this site constitutes agreement to its user agreement and privacy policy.

Automated Insights